National Bone Health Alliance
Strong Bones America
1.855.742.8179
Call for information

Mechanistic and Therapeutic Insights into Skeletal Biology Learned from the Study of Rare Bone Diseases

275.jpg

Thursday, September 11th, 2014 (One day prior to the ASBMR 2014 Annual Meeting)

George R. Brown Convention Center, 1001 Avenida De Las Americas, Houston, TX 

Workshop Summary:  To date, nearly 500 unique rare bone diseases have been described, which in the aggregate affect 1 in 5,000 live births, and comprise 5% of all birth defects. Typically the disability caused by these diseases affects individuals throughout their lives. Currently, the vast majority of these disorders have no cure, yet studying rare bone diseases has helped elucidate biological pathways and reveal valuable targets for drug discovery that are benefitting patients with common bone diseases too.

This workshop, coordinated by the National Bone Health Alliance (NBHA) in partnership with the Rare Bone Disease Patient Network and with the support of the American Society for Bone and Mineral Research (ASBMR) and the United States Bone and Joint Initiative (USBJI) aims to:

1)     Convene a multi-disciplinary group of experts including researchers, clinicians, and patients with rare bone diseases to advance our understanding of skeletal biology and encourage the development of novel therapies to improve outcomes for individuals with both common and rare bone diseases;

2)     Identify gaps in our knowledge regarding the biologic mechanisms underlying rare bone disorders and share effective research strategies in translational and therapeutic areas;

3)     Encourage broad participation both by holding the event the day before the ASBMR 2014 Annual Meeting and providing funding for a significant number of young investigators to attend; and

4)     Disseminate the results broadly by publishing the proceedings of the program in a peer-reviewed journal.

The one-day workshop will include lectures by invited speakers, and multiple opportunities to initiate collaborations and encourage future research partnerships.

Click here to view the preliminary agenda.

Click here to view the members of the NBHA Rare Bone Disease Working Group and Rare Bone Disease Patient Network.

Register for this workshop via the ASBMR Annual Meeting website: http://www.asbmr.org/annual-meeting

This workshop is supported in part by unrestricted educational grants from the following companies:

 328.jpg329.jpg330.jpg

News

2014-10-14

NOF, NBHA and CE City, Inc. Launch a New Osteoporosis Quality Improvement Registry

The NOF and NBHA Osteoporosis Quality Improvement Registry (QIR), developed in collaboration with CECity, Inc., as a Qualified Clinical Data Registry (QCDR) for the CMS Physician Quality Reporting System (PQRS) in the 2014 program year officially launched today at www.medconcert.com/FractureQIR.

Member spotlight

DePuy Synthes

At the DePuy Synthes Companies, we listen to the moving stories of patients experiencing orthopaedic and neurological conditions and to the healthcare professionals who treat them. Then we deliver total solutions to help people live full lives.